Role of folic acid on symptoms of chronic arsenic toxicity

International Journal of Preventive Medicine

Volumn 5, Issue 1, 2014, Pages 89-98

  Ghose, Nelima ^a   Majumdar, Kunal Kanti ^b   Ghose, A K ^a   Saha, C K ^c   Nandy, A K ^c   Mazumder, D N Guha ^a  

^a DNGM Research Foundation   (India)

^b MEDICAL COLLEGE AND HOSPITAL   (India)

^c CALCUTTA SCHOOL OF TROPICAL MEDICINE   (India)

Author keywords

Arsenicosis; Folic acid; Nutritional deficiency; Treatment of arsenicosis

Indexed keywords

ARSENIC; DRINKING WATER; FOLIC ACID;

ADULT; ARSENIC POISONING; ARTICLE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FLUID INTAKE; HUMAN; MALE; SAFETY; SKIN DEFECT; SYSTEMIC DISEASE; TREATMENT DURATION; WATER CONTAMINATION;

EID: 84893070548     PISSN: 20087802     EISSN: 20088213     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Piamphongsant T. Chronic environmental arsenic poisoning. Int J Dermatology 1999;38:401-10.
2. Guha Mazumder DN, Ghoshal UC, Saha J, Santra A, De BK, Chatterjee A, et al. Randomized placebo-controlled trial of 2, 3-dimercaptosuccinic acid in therapy of chronic arsenicosis due to drinking arsenic-contaminated subsoil water. J Toxicol Clin Toxicol 1998;36:683-90.
3. Guha Mazumder DN, De BK, Santra A, Ghosh N, Das S, Lahiri S, et al. Randomized placebo-controlled trial of 2, 3-dimercapto-1-propanesulfonate (DMPS) in therapy of chronic arsenicosis due to drinking contaminated water. J Toxicol Clin Toxicol 2001;39:665-74.
4. Ahmad SA, Faruquee MH, Sayed MH, Khan MH, Jalil MA, Ahmed R, et al. Chronic arsenicosis: Management by vitamin A, E, Cregimen. J Prev Soc Med 1998;17:19-26.
5. Guha Mazumder DN, Ghosh N, Mazumder K, Santra A, Lahiri S, Das S, Basu A, Smith AH. Natural History Following Arsenic Exposure. A Study in an Arsenic Endemic Area of West Bengal, India. In: Chappell WR, Abernathy CO, Calderon RL, Thomas DJ, eds. Arsenic Exposure and Health Effects. London, UK, Elsevier Science 2003:381-390.
6. Oshikawa S, Geater A, Chongsuvivatwong V, Piampongsan T, Chakraborti D, Samanta G, et al. Long-term changes in severity of arsenical skin lesions following intervention to reduce arsenic exposure. Environ Sci 2001;8:435-48.
7. Chen YC, Guo YL, Su HJ, Hsueh YM, Smith TJ, Ryan LM, et al. Arsenic methylation and skin cancer risk in South western Taiwan. J Occup Environ Med 2003;45:241
8. Chen YC, Su HJ, Guo YL, Hsueh YM, Smith TJ, Ryan LM, et al. Arsenic methylation and bladder cancer risk in Taiwan. Cancer Causes Control 2003;14:303-10.
9. Hsueh YM, Chiou HY, Huang YL, Wu WL, Huang CC, Yang MH, et al. Serum beta-carotene level, arsenic methylation capability, and incidence of skin cancer. Cancer Epidemiol Biomarkers Prev 1997;6:589-96.
10. Yu RC, Hsu KH, Chen CJ, Froines JR. Arsenic methylation capacity and skin cancer. Cancer Epidemiol Biomakers Prev 2000; 9:1259-62.
11. Tseng CH, Huang YK, Huang YL, Chung CJ, Yang MH, Chen CJ, et al. Arsenic exposure, urinary arsenic speciation and peripheral vascular disease in black foot disease-hyper endemic villages in Taiwan. Toxicol Appl Pharmacol 2005;206:299-308.
12. Gamble MV, Ahsan H, Liu X, Factor-Litvak P, Ilievski V, Slavkovich V, et al. Folate and cobalamin deficiencies and hyperhomocysteinemia in Bangladesh. Am JClin Nutr 2005;1:1372-7.
13. Hopenhayn-Rich C, Biggs ML, Smith AH, Kalman DA, Moore LE. Methylation study of a population environmentally exposed to arsenic in drinking water. Environ Health Perspect 1996;104:620-8.
14. Vahter M, Marafante E. Effects of low dietary intake of methionine, choline or proteins on the biotransformation of arsenite in the rabbit. Toxicol Lett 1987;37:41-6.
15. Tice RR, Yager JW, Andrews P, Crecelius E. Effect of hepatic methyl donor status on urinary excretion and DNA damage in B6C3F1 mice treated with sodium arsenite. Mutat Res 1997; 386:315-34.
16. Spiegelstein O, Lu X, Le XC, Troen A, Selhub J, Melnyk S, et al. Effects of dietary folate intake and folate binding protein-1 (Folbp1) on urinary speciation of sodium arsenate in mice. Toxicol Lett 2003;145:167-74.
17. Spiegelstein O, Gould A, Wlodarczyk B, Tsie M, Lu X, Le C, et al. Developmental consequences of in utero sodium arsenate exposure in mice with folate transport deficiencies. Toxicol Appl Pharmacol 2005;203:18-26.
18. Mitra SR, Mazumder DN, Basu A, Block G, Haque R, Samanta S, et al. Nutritional factors and susceptibility to arsenic-caused skin lesions in West Bengal, India. Environ Health Perspect 2004;12:1104-9.
19. Zablotska LB, Chen Y, Graziano JH, Parvez F, van Geen A, Howe GR, et al. Protective effects of B vitamins and antioxidants on the risk of arsenic-related skin lesions in Bangladesh. Environ Health Perspect 2008;116:1056-62.
20. Mazumder DN, Ghosh A, Majumdar KK, Ghosh N, Saha C, Mazumder RN. Arsenic contamination of ground water and its health impact on population of district of Nadia, West Bengal, India. Indian J Community Med 2010;35:331-8.
21. Gamble MV, Liu X, Ahsan H, Pilsner R, Ilievski V, Slavkovich V, et al. homocysteine and arsenic metabolism in Bangladesh. Environ Health Perspect 2005;113:1683-8.
22. Buchet JP, Lauwerys R, Roels H. Comparison of the urinary excretion of arsenic metabolites after a single oral doses of sodium arsenite, monomethylarsonate, or dimethylarsinate in man. Int Arch Occup Environ Health 1981;48:71-9.
23. Vahter M, Concha G. Role of metabolism in arsenic toxicity. Pharmacol Toxicol 2001;89:1-5.
24. Donohue, JM, and Abernathy, CO (2001). Arsenic methylation and the S-adenosylmethionine-mediated transmethylation/transsulfuration pathway. In Arsenic Exposure and Health Effects IV (WR Chappel, CO Abernathy, and RL Calderon, Eds.), p. 367-9.
25. Yi P, Melnyk S, Pogribna M, Pogribny IP, Hine RJ, James SJ. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J Biol Chem 2000;275:29318-23.
26. De Kimpe J, Cornelis R, Vanholder R. In vitro methylation of arsenite by rabbit liver cystosol: Effect of metal ions, metal chelating agents, methyltransferase inhibitors and uremic toxins. Drug Chem Toxicol 1999;22:613-28.
27. Gamble MV, Liu X, Ahsan H, Pilsner JR, Ilievski V, Slavkovich V, et al. Folate and arsenic metabolism: Adouble-blind, placebo-controlled folic acid-supplementation trial in Bangladesh. Am J Clin Nutr 2006;84:1093-101.
28. Chowdhury UK, Rahman MM, Mondal BK, Paul K, Lodh D, Biswas BK, et al. Groundwater arsenic contamination and human suffering in West Bengal, India and Bangladesh. Environ Sci 2001;8:393-415.
29. Roychowdhury T, Uchino T, Tokunaga H, Ando M. Survey of arsenic in food composites from an arsenic-affected area of West Bengal, India. Food Chem Toxicol 2002;40:1611-21.
30. Guha Mazumder DN. Health effects of chronic arsenic toxicity with special reference to arsenic in food chain. Proceedings of International Workshop on Updates in Arsenic-related Health Effects. Kaohsiung Medical University, Kaohsiung, Taiwan; 2008. p. 72.
31. Guha Mazumder DN. Chronic arsenic toxicity: Clinical features, epidemiology and treatment: Experience in West Bengal. J Environ Sci Health A Tox Hazard Subst Environ Eng 2003;38:141-63.